David M Parham Selected Research

Embryonal Rhabdomyosarcoma

9/2017	45 Gy is not sufficient radiotherapy dose for Group III orbital embryonal rhabdomyosarcoma after less than complete response to 12 weeks of ARST0331 chemotherapy: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
6/2017	Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
11/2014	Shorter-duration therapy using vincristine, dactinomycin, and lower-dose cyclophosphamide with or without radiotherapy for patients with newly diagnosed low-risk rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
7/2013	Dense pattern of embryonal rhabdomyosarcoma, a lesion easily confused with alveolar rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
4/2011	Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
4/2005	Upstream CpG island methylation of the PAX3 gene in human rhabdomyosarcomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David M Parham Research Topics

Disease

20	Neoplasms (Cancer) 04/2024 - 03/2002
13	Rhabdomyosarcoma 01/2019 - 05/2006
7	Sarcoma (Soft Tissue Sarcoma) 04/2024 - 04/2011
6	Embryonal Rhabdomyosarcoma 09/2017 - 04/2005
3	Alveolar Rhabdomyosarcoma 10/2010 - 04/2005
2	Residual Neoplasm 04/2024 - 01/2017
2	Disease Progression 01/2019 - 10/2010
1	Rupture 04/2024
1	Margins of Excision 04/2024
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Anaplasia 01/2021
1	Wounds and Injuries (Trauma) 01/2020
1	Dermatofibrosarcoma 01/2020
1	Osteosarcoma (Osteogenic Sarcoma) 01/2018
1	Infertility (Sterility) 09/2017
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2017
1	Hamartoma 01/2017
1	Breast Neoplasms (Breast Cancer) 01/2017
1	Hepatocellular Carcinoma (Hepatoma) 12/2015
1	Hepatoblastoma 12/2015
1	Granuloma 12/2014
1	Entropion 12/2014
1	Foreign Bodies (Foreign Body) 12/2014
1	Dermatomyositis (Dermatopolymyositis) 03/2013
1	Hyperplasia 09/2012
1	Lung Diseases (Lung Disease) 09/2012
1	Emphysema 09/2012
1	Arteriosclerosis 09/2012
1	Schimke immunoosseous dysplasia 09/2012
1	Aicardi Syndrome 01/2011
1	Lymphedema (Milroy Disease) 01/2011
1	Hemangioma (Angioma) 01/2011
1	Melanotic Neuroectodermal Tumor 03/2007
1	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 02/2007
1	Wilms Tumor (Wilm's Tumor) 02/2007
1	Necrosis 08/2006
1	Fat Embolism 05/2006
1	Scoliosis 05/2006
1	Carcinogenesis 03/2003

Drug/Important Bio-Agent (IBA)

7	Vincristine (Oncovin)FDA LinkGeneric 01/2018 - 11/2009
6	MyogeninIBA 03/2021 - 11/2004
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018 - 11/2009
5	Dactinomycin (Actinomycin)FDA LinkGeneric 01/2018 - 11/2009
3	DNA (Deoxyribonucleic Acid)IBA 11/2018 - 03/2003
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2018 - 10/2010
2	DesminIBA 03/2021 - 11/2004
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2014
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 12/2015
2	ChromatinIBA 09/2012 - 10/2010
2	ParaffinIBA 06/2006 - 05/2006
1	Histones (Histone)IBA 04/2024
1	Lysine (L-Lysine)FDA Link 04/2024
1	Indicators and Reagents (Reagents)IBA 01/2021
1	cixutumumabIBA 01/2019
1	Temozolomide (Temodar)FDA LinkGeneric 01/2019
1	epacadostatIBA 01/2018
1	human ERBB2 proteinIBA 01/2017
1	Trastuzumab (Herceptin)FDA Link 01/2017
1	Monoclonal AntibodiesIBA 01/2017
1	Etoposide (VP 16)FDA LinkGeneric 01/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016
1	Ifosfamide FDA LinkGeneric 01/2016
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 12/2015
1	GlypicansIBA 12/2015
1	delta proteinIBA 12/2015
1	Claudin-1IBA 12/2015
1	CateninsIBA 12/2015
1	Polyglycolic Acid (Polyglycolide)IBA 12/2014
1	ElementsIBA 12/2014
1	Contrast MediaIBA 12/2014
1	ElastinIBA 09/2012
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 10/2010
1	Topotecan (Hycamtin)FDA LinkGeneric 11/2009
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 02/2007
1	Coloring Agents (Dyes)IBA 02/2007
1	Formaldehyde (Formol)FDA Link 05/2006
1	EnzymesIBA 04/2005
1	Culture MediaIBA 03/2004
1	Satellite DNA (Satellite DNAs)IBA 03/2003
1	HeterochromatinIBA 03/2003

Therapy/Procedure

10	Therapeutics 01/2020 - 03/2002
8	Radiotherapy 04/2024 - 10/2010
8	Drug Therapy (Chemotherapy) 04/2024 - 03/2002
3	Neoadjuvant Therapy 04/2024 - 01/2017
1	Chemoradiotherapy 01/2020
1	Surgical Amputation (Amputations) 01/2017
1	Sutures (Suture) 12/2014
1	Immunomodulation 03/2013
1	Liver Transplantation 06/2007
1	Spinal Fusion (Spondylosyndesis) 05/2006